Accuray (ARAY) Cash from Financing Activities (2010 - 2026)

Accuray's (ARAY) quarterly Cash from Financing Activities came in at $4.1 million in Q1 2026, up 158.0% year-on-year from $1.6 million in Q1 2025, and up 1557.45% quarter-over-quarter from -$282000.0 in Q4 2025.

Accuray (ARAY) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Accuray's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 158.0% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 156.4% increase from a year earlier, with the FY2025 full-year figure at -$4.3 million, down 7.62% from the prior year.
  • Cash from Financing Activities rose to $4.1 million in Q1 2026 per ARAY's latest filing, from -$282000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $5.8 million in Q4 2024 and bottomed at -$15.5 million in Q1 2022.
  • The 5-year median for Cash from Financing Activities is -$475000.0 (2025), against an average of -$1.1 million.
  • Across the five-year window, Cash from Financing Activities slumped 336.5% in 2022 and jumped 2343.58% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $4.3 million in 2022, then plunged by 106.01% to -$257000.0 in 2023, then soared by 2343.58% to $5.8 million in 2024, then plunged by 104.89% to -$282000.0 in 2025, then surged by 1557.45% to $4.1 million in 2026.
  • Per Business Quant, the three latest ARAY Cash from Financing Activities figures stand at $4.1 million (Q1 2026), -$282000.0 (Q4 2025), and -$475000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 180.89 Bn 173.59 Bn 6.27 Bn 17.31 Bn
2 Stryker 127.82 Bn 124.94 Bn 3.81 Bn -1.51 Bn
3 Medtronic 107.49 Bn 98.27 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 67.24 Bn 65.78 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 48.02 Bn 44.34 Bn 1.29 Bn -451.20 Mn
6 Dexcom 28.25 Bn 27.14 Bn 750.30 Mn -25.00 Mn
7 GE HealthCare Technologies 28.17 Bn 25.89 Bn 1.98 Bn 21.00 Mn
8 Smith & Nephew 26.72 Bn 26.14 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn -26.93 Mn
10 Accuray 29,112.00 -38.50 Mn 25.29 Mn 4.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.11 Mn
Mar 31, 2026 4.11 Mn
Dec 31, 2025 -282,000.00
Dec 31, 2025 -282,000.00
Sep 30, 2025 -475,000.00
Sep 30, 2025 -475,000.00
Mar 31, 2025 1.59 Mn
Mar 31, 2025 1.59 Mn
Dec 31, 2024 5.77 Mn
Dec 31, 2024 5.77 Mn
Sep 30, 2024 -2.17 Mn
Sep 30, 2024 -2.17 Mn
Mar 31, 2024 -3.26 Mn
Mar 31, 2024 -3.26 Mn
Dec 31, 2023 -257,000.00
Dec 31, 2023 -257,000.00
Sep 30, 2023 -1.50 Mn
Sep 30, 2023 -1.50 Mn
Mar 31, 2023 -1.59 Mn
Mar 31, 2023 -1.59 Mn